|
Volume 272, Number 26,
Issue of June 27, 1997
pp. 16231-16239
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Novel Function of Lecithin-Cholesterol Acyltransferase
HYDROLYSIS OF OXIDIZED POLAR PHOSPHOLIPIDS GENERATED DURING
LIPOPROTEIN OXIDATION
(Received for publication, November 4, 1996, and in revised form, February 25, 1997)
Jaya
Goyal
,
Kewei
Wang
,
Ming
Liu
and
Papasani V.
Subbaiah
From the Departments of Medicine and Biochemistry, Rush Medical
College, Chicago, Illinois 60612
Although the major function of
lecithin-cholesterol acyltransferase (LCAT) is cholesterol
esterification, our previous studies showed that it can also hydrolyze
platelet-activating factor (PAF). Because of the structural
similarities between PAF and the truncated phosphatidylcholines (polar
PCs) generated during lipoprotein oxidation, we investigated the
possibility that LCAT may also hydrolyze polar PCs to lyso-PC during
the oxidation of plasma. PAF acetylhydrolase (PAF-AH), which is known
to hydrolyze polar PCs in human plasma, was completely inhibited by 0.2 mM p-aminoethyl benzenesulfonyl
fluoride (Pefabloc), a new serine esterase inhibitor, which had no
effect on LCAT at this concentration. On the other hand, 1 mM diisopropylfluorophosphate (DFP) completely inhibited LCAT but had no effect on PAF-AH. Polar PC accumulation during the
oxidation of plasma increased by 44% in the presence of 0.2 mM Pefabloc and by 30% in the presence of 1 mM
DFP. The formation of lyso-PC was concomitantly inhibited by both of
the inhibitors. The combination of the two inhibitors resulted in the
maximum accumulation of polar PCs, suggesting that both PAF-AH and LCAT are involved in their breakdown. Oxidation of chicken plasma, which has
no PAF-AH activity, also resulted in the formation of lyso-PC from the
hydrolysis of polar PC, which was inhibited by DFP. Polar PCs, either
isolated from oxidized plasma or by oxidation of labeled synthetic PCs,
were hydrolyzed by purified LCAT, which had no detectable PAF-AH
activity. These results demonstrate a novel function for LCAT in the
detoxification of polar PCs generated during lipoprotein oxidation,
especially when the PAF-AH is absent or inactivated.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
H. S. Seo, J. H. Kim, and M. H. Nahm
Platelet-Activating Factor-Acetylhydrolase Can Monodeacylate and Inactivate Lipoteichoic Acid
Clin. Vaccine Immunol.,
April 1, 2006;
13(4):
452 - 458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H.E.M. Klerkx, K. E. Harchaoui, W. A. van der Steeg, S. M. Boekholdt, E. S.G. Stroes, J. J.P. Kastelein, and J. A. Kuivenhoven
Cholesteryl Ester Transfer Protein (CETP) Inhibition Beyond Raising High-Density Lipoprotein Cholesterol Levels: Pathways by Which Modulation of CETP Activity May Alter Atherogenesis
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2006;
26(4):
706 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Moore, M. Navab, J. S. Millar, F. Zimetti, S. Hama, G. H. Rothblat, and D. J. Rader
Increased Atherosclerosis in Mice Lacking Apolipoprotein A-I Attributable to Both Impaired Reverse Cholesterol Transport and Increased Inflammation
Circ. Res.,
October 14, 2005;
97(8):
763 - 771.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Srivastava, M. Spite, J. O. Trent, M. B. West, Y. Ahmed, and A. Bhatnagar
Aldose Reductase-catalyzed Reduction of Aldehyde Phospholipids
J. Biol. Chem.,
December 17, 2004;
279(51):
53395 - 53406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush
Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity
J. Clin. Endocrinol. Metab.,
October 1, 2004;
89(10):
4963 - 4971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Stahl, A. S. Carlsson, M. Lenman, A. Dahlqvist, B. Huang, W. Banas, A. Banas, and S. Stymne
Cloning and Functional Characterization of a Phospholipid:Diacylglycerol Acyltransferase from Arabidopsis
Plant Physiology,
July 1, 2004;
135(3):
1324 - 1335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kontush, S. Chantepie, and M. J. Chapman
Small, Dense HDL Particles Exert Potent Protection of Atherogenic LDL Against Oxidative Stress
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2003;
23(10):
1881 - 1888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Blankenberg, D. Stengel, H. J. Rupprecht, C. Bickel, J. Meyer, F. Cambien, L. Tiret, and E. Ninio
Plasma PAF-acetylhydrolase in patients with coronary artery disease: results of a cross-sectional analysis
J. Lipid Res.,
July 1, 2003;
44(7):
1381 - 1386.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Boisfer, D. Stengel, D. Pastier, P. M. Laplaud, N. Dousset, E. Ninio, and A.-D. Kalopissis
Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II
J. Lipid Res.,
May 1, 2002;
43(5):
732 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Forte, G. Subbanagounder, J. A. Berliner, P. J. Blanche, A. O. Clermont, Z. Jia, M. N. Oda, R. M. Krauss, and J. K. Bielicki
Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice
J. Lipid Res.,
March 1, 2002;
43(3):
477 - 485.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Navab, S. Y. Hama, G. P. Hough, G. Subbanagounder, S. T. Reddy, and A. M. Fogelman
A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids
J. Lipid Res.,
August 1, 2001;
42(8):
1308 - 1317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Navab, J. A. Berliner, G. Subbanagounder, S. Hama, A. J. Lusis, L. W. Castellani, S. Reddy, D. Shih, W. Shi, A. D. Watson, et al.
HDL and the Inflammatory Response Induced by LDL-Derived Oxidized Phospholipids
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2001;
21(4):
481 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ruiz, M. H. Kuehn, J. L. Andorf, E. Stone, G. S. Hageman, and D. Bok
Genomic Organization and Mutation Analysis of the Gene Encoding Lecithin Retinol Acyltransferase in Human Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci.,
January 1, 2001;
42(1):
31 - 37.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Bart De Geest, D. Stengel, M. Landeloos, M. Lox, L. Le Gat, D. Collen, P. Holvoet, and E. Ninio
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E-Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase : Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2000;
20
(10):
e68 - e75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tokumura, T. Sumida, M. Toujima, K. Kogure, K. Fukuzawa, Y. Takahashi, and S. Yamamoto
Structural identification of phosphatidylcholines having an oxidatively shortened linoleate residue generated through its oxygenation with soybean or rabbit reticulocyte lipoxygenase
J. Lipid Res.,
June 1, 2000;
41(6):
953 - 962.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott
Biologically Active Oxidized Phospholipids
J. Biol. Chem.,
September 3, 1999;
274(36):
25189 - 25192.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Karasawa, X. Qiu, and T.-c. Lee
Purification and Characterization from Rat Kidney Membranes of a Novel Platelet-activating Factor (PAF)-dependent Transacetylase That Catalyzes the Hydrolysis of PAF, Formation of PAF Analogs, and C2-ceramide
J. Biol. Chem.,
March 26, 1999;
274(13):
8655 - 8661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Liu, R. W. St. Clair, and P. V. Subbaiah
Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: possible effects on metabolism of oxidized phospholipids
J. Lipid Res.,
February 1, 1998;
39(2):
245 - 254.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|